Vaxcyte
PCVX
$68.70
Share price
-0.09%
Change (1 day)
40.29%
Change (1 year)
Categories
Vaxcyte (PCVX) - P/B ratio
P/B ratio as of May 2024 : 3.77
According to Vaxcyte
's latest financial reports the company has a price-to-book ratio of 3.77.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Vaxcyte - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 4.82 | 21.3% |
| 2022-12-31 | 3.97 | -10.18% |
| 2021-12-31 | 4.42 | 12.96% |
| 2020-12-31 | 3.91 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.81 | -52.02% | 🇺🇸 USA |